Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, which bodies are responsible for (a) monitoring (i) shortages and (ii) unavailability of NHS prescription medicines, (b) overseeing the manufacturing locations of brands licensed for use in the UK and (c) assessing potential supply risks where multiple brands are produced by the same third-party manufacturer.

The Department has overall policy, strategic, and operational responsibility for ensuring the continuity of the supply of medicines to the National Health Service in England. The Department works closely with NHS England, which has delegated responsibility for managing the continuity of supply for medicines procured on Medicines Procurement and Supply Chain Team frameworks. Manufacturers have a legal requirement to inform the Department of any supply issues. We work closely with industry, the NHS, manufacturers, and other partners across the supply chain to make sure patients across the United Kingdom can access the medicines they need.

The supply of medicines, including procurement, storage, allocation, and distribution is a devolved matter. However, we regularly engage with the devolved administrations to discuss potential supply issues.

The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices, and blood components for transfusion in the UK. The Home Office issues controlled drug licences for companies that possess, manufacture, produce, or supply controlled drugs in England, Wales, or Scotland, and Department of Health (Northern Ireland) for Northern Ireland.